| 0 |
ELECTRODESICCATION |
4 |
0.6667 |
| 1 |
B-CELL SMALL LYMPHOCYTIC LYMPHOMA RECURRENT |
6 |
0.2727 |
| 2 |
ASCENDING FLACCID PARALYSIS |
5 |
0.1852 |
| 3 |
CHONDROSARCOMA METASTATIC |
4 |
0.1481 |
| 4 |
MANTLE CELL LYMPHOMA RECURRENT |
58 |
0.1333 |
| 5 |
FOLLICULAR LYMPHOMA RECURRENT |
10 |
0.1250 |
| 6 |
INFUSION SITE PHLEBITIS |
27 |
0.1184 |
| 7 |
EXPOSURE VIA CONTAMINATED DEVICE |
5 |
0.1136 |
| 8 |
FOLLICULAR LYMPHOMA REFRACTORY |
7 |
0.1077 |
| 9 |
LYMPHOMA TRANSFORMATION |
36 |
0.1000 |
| 10 |
ERYTHROPOIESIS ABNORMAL |
25 |
0.0817 |
| 11 |
CORONAVIRUS PNEUMONIA |
13 |
0.0778 |
| 12 |
APOPTOTIC COLONOPATHY |
6 |
0.0723 |
| 13 |
PARANEOPLASTIC PEMPHIGUS |
8 |
0.0615 |
| 14 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
46 |
0.0597 |
| 15 |
TUMOUR OBSTRUCTION |
5 |
0.0575 |
| 16 |
FOLLICULAR LYMPHOMA |
47 |
0.0534 |
| 17 |
METASTASES TO RETROPERITONEUM |
9 |
0.0529 |
| 18 |
LEUKAEMIA CUTIS |
8 |
0.0519 |
| 19 |
INJECTION SITE PHLEBITIS |
12 |
0.0513 |
| 20 |
METASTASES TO MUSCLE |
9 |
0.0497 |
| 21 |
CYTOMEGALOVIRUS CHORIORETINITIS |
88 |
0.0451 |
| 22 |
BREAKTHROUGH COVID-19 |
10 |
0.0435 |
| 23 |
VASOGENIC CEREBRAL OEDEMA |
28 |
0.0389 |
| 24 |
CD4 LYMPHOCYTES DECREASED |
81 |
0.0378 |
| 25 |
ASPIRATION BONE MARROW ABNORMAL |
5 |
0.0370 |
| 26 |
HUMORAL IMMUNE DEFECT |
13 |
0.0350 |
| 27 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
77 |
0.0349 |
| 28 |
MANTLE CELL LYMPHOMA |
51 |
0.0335 |
| 29 |
CYTOMEGALOVIRUS TEST POSITIVE |
57 |
0.0320 |
| 30 |
THERAPY RESPONDER |
15 |
0.0305 |
| 31 |
POLYCHROMASIA |
9 |
0.0300 |
| 32 |
INFUSION SITE IRRITATION |
38 |
0.0296 |
| 33 |
ATYPICAL MYCOBACTERIAL PNEUMONIA |
4 |
0.0288 |
| 34 |
CELL-MEDIATED IMMUNE DEFICIENCY |
4 |
0.0286 |
| 35 |
CYTOMEGALOVIRUS GASTROENTERITIS |
6 |
0.0278 |
| 36 |
ALOPECIA SCARRING |
5 |
0.0273 |
| 37 |
NASAL ABSCESS |
6 |
0.0260 |
| 38 |
B-CELL LYMPHOMA RECURRENT |
14 |
0.0258 |
| 39 |
CYTOMEGALOVIRUS HEPATITIS |
9 |
0.0254 |
| 40 |
CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT |
17 |
0.0244 |
| 41 |
BONE MARROW INFILTRATION |
9 |
0.0233 |
| 42 |
ENCEPHALITIS CYTOMEGALOVIRUS |
10 |
0.0228 |
| 43 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
108 |
0.0227 |
| 44 |
LISTERIA SEPSIS |
6 |
0.0227 |
| 45 |
EXTRAVASATION |
93 |
0.0226 |
| 46 |
POST-ACUTE COVID-19 SYNDROME |
28 |
0.0226 |
| 47 |
DIFFUSE LARGE B-CELL LYMPHOMA |
174 |
0.0226 |
| 48 |
METASTASES TO BONE MARROW |
11 |
0.0220 |
| 49 |
METASTASES TO SPLEEN |
9 |
0.0218 |
| 50 |
HYPERTENSIVE CARDIOMYOPATHY |
6 |
0.0216 |
| 51 |
CEREBRAL ASPERGILLOSIS |
13 |
0.0211 |
| 52 |
GRANULOMA SKIN |
17 |
0.0207 |
| 53 |
SKIN NEOPLASM EXCISION |
16 |
0.0204 |
| 54 |
HYPOGAMMAGLOBULINAEMIA |
127 |
0.0193 |
| 55 |
PNEUMONIA CYTOMEGALOVIRAL |
36 |
0.0185 |
| 56 |
IMMUNODEFICIENCY COMMON VARIABLE |
9 |
0.0184 |
| 57 |
ECTHYMA |
7 |
0.0175 |
| 58 |
URETHRAL OBSTRUCTION |
7 |
0.0173 |
| 59 |
APLASIA PURE RED CELL |
58 |
0.0168 |
| 60 |
TUMOUR LYSIS SYNDROME |
148 |
0.0168 |
| 61 |
PLASMA CELL LEUKAEMIA |
10 |
0.0167 |
| 62 |
CLOSTRIDIAL SEPSIS |
4 |
0.0165 |
| 63 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
73 |
0.0165 |
| 64 |
NEUROENDOCRINE CARCINOMA OF THE SKIN |
16 |
0.0163 |
| 65 |
CYTOMEGALOVIRUS INFECTION |
271 |
0.0163 |
| 66 |
INFUSION SITE REACTION |
48 |
0.0161 |
| 67 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
132 |
0.0160 |
| 68 |
GASTROINTESTINAL FUNGAL INFECTION |
8 |
0.0155 |
| 69 |
BETA 2 MICROGLOBULIN INCREASED |
4 |
0.0153 |
| 70 |
COAGULATION FACTOR V LEVEL DECREASED |
5 |
0.0153 |
| 71 |
HUMAN POLYOMAVIRUS INFECTION |
8 |
0.0151 |
| 72 |
CYTOMEGALOVIRUS VIRAEMIA |
67 |
0.0150 |
| 73 |
VEIN DISCOLOURATION |
7 |
0.0149 |
| 74 |
LYMPHOCYTE COUNT DECREASED |
263 |
0.0149 |
| 75 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
14 |
0.0148 |
| 76 |
PNEUMONIA ESCHERICHIA |
5 |
0.0147 |
| 77 |
WOUND NECROSIS |
7 |
0.0146 |
| 78 |
CYTOPENIA |
174 |
0.0142 |
| 79 |
PRESCRIBED UNDERDOSE |
276 |
0.0138 |
| 80 |
ERYTHEMA ANNULARE |
4 |
0.0138 |
| 81 |
OBLITERATIVE BRONCHIOLITIS |
18 |
0.0137 |
| 82 |
CYSTITIS VIRAL |
5 |
0.0131 |
| 83 |
CONGENITAL APLASIA |
4 |
0.0129 |
| 84 |
COVID-19 PNEUMONIA |
146 |
0.0124 |
| 85 |
ENTEROCOCCAL SEPSIS |
10 |
0.0123 |
| 86 |
KLEBSIELLA TEST POSITIVE |
8 |
0.0123 |
| 87 |
SINUS POLYP |
7 |
0.0121 |
| 88 |
ANAEMIA HAEMOLYTIC AUTOIMMUNE |
10 |
0.0121 |
| 89 |
ORAL LICHEN PLANUS |
6 |
0.0120 |
| 90 |
PROCALCITONIN INCREASED |
14 |
0.0119 |
| 91 |
OPPORTUNISTIC INFECTION |
22 |
0.0119 |
| 92 |
TUMOUR FLARE |
8 |
0.0117 |
| 93 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
182 |
0.0115 |
| 94 |
BLOOD PARATHYROID HORMONE DECREASED |
17 |
0.0115 |
| 95 |
FUNGAL TEST POSITIVE |
4 |
0.0114 |
| 96 |
INFUSION SITE EXTRAVASATION |
71 |
0.0114 |
| 97 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
39 |
0.0114 |
| 98 |
FUNGAL OESOPHAGITIS |
8 |
0.0113 |
| 99 |
VIRAL HAEMORRHAGIC CYSTITIS |
8 |
0.0112 |
| 100 |
HEPATITIS VIRAL |
9 |
0.0112 |
| 101 |
PNEUMONIA PSEUDOMONAL |
17 |
0.0111 |
| 102 |
CORONAVIRUS INFECTION |
71 |
0.0107 |
| 103 |
ANISOCYTOSIS |
7 |
0.0107 |
| 104 |
PLASMA CELL MYELOMA REFRACTORY |
14 |
0.0105 |
| 105 |
NEUTROPHIL COUNT DECREASED |
424 |
0.0104 |
| 106 |
ABDOMINAL LYMPHADENOPATHY |
9 |
0.0104 |
| 107 |
CANDIDA SEPSIS |
9 |
0.0100 |
| 108 |
B-CELL LYMPHOMA |
34 |
0.0100 |
| 109 |
NON-HODGKIN'S LYMPHOMA |
13 |
0.0099 |
| 110 |
SCROTAL OEDEMA |
7 |
0.0098 |
| 111 |
HEPATITIS B REACTIVATION |
31 |
0.0098 |
| 112 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
7 |
0.0097 |
| 113 |
B-LYMPHOCYTE COUNT DECREASED |
13 |
0.0095 |
| 114 |
CYTOMEGALOVIRUS COLITIS |
21 |
0.0091 |
| 115 |
ORGANISING PNEUMONIA |
45 |
0.0091 |
| 116 |
NEOPLASM SKIN |
14 |
0.0090 |
| 117 |
PULMONARY MYCOSIS |
7 |
0.0090 |
| 118 |
IMMUNE THROMBOCYTOPENIC PURPURA |
25 |
0.0088 |
| 119 |
BIOPSY BONE MARROW ABNORMAL |
4 |
0.0088 |
| 120 |
FEBRILE INFECTION |
10 |
0.0085 |
| 121 |
PNEUMOCOCCAL INFECTION |
5 |
0.0084 |
| 122 |
VACCINATION FAILURE |
14 |
0.0084 |
| 123 |
ORAL FUNGAL INFECTION |
23 |
0.0084 |
| 124 |
CRYOGLOBULINAEMIA |
6 |
0.0084 |
| 125 |
PHLEBITIS |
43 |
0.0084 |
| 126 |
MYELODYSPLASTIC SYNDROME |
121 |
0.0084 |
| 127 |
MALIGNANT PLEURAL EFFUSION |
14 |
0.0083 |
| 128 |
PANNICULITIS |
20 |
0.0083 |
| 129 |
VARICELLA ZOSTER VIRUS INFECTION |
17 |
0.0082 |
| 130 |
JC VIRUS INFECTION |
13 |
0.0081 |
| 131 |
EVANS SYNDROME |
4 |
0.0081 |
| 132 |
BLOOD IMMUNOGLOBULIN G DECREASED |
20 |
0.0081 |
| 133 |
FEBRILE NEUTROPENIA |
534 |
0.0080 |
| 134 |
EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) |
4 |
0.0079 |
| 135 |
MYELOSUPPRESSION |
282 |
0.0078 |
| 136 |
DEMYELINATING POLYNEUROPATHY |
8 |
0.0078 |
| 137 |
MUCOSAL EROSION |
7 |
0.0077 |
| 138 |
HEPATITIS E |
12 |
0.0076 |
| 139 |
CHRONIC MYELOMONOCYTIC LEUKAEMIA |
5 |
0.0076 |
| 140 |
SECOND PRIMARY MALIGNANCY |
63 |
0.0076 |
| 141 |
VULVAL DISORDER |
5 |
0.0076 |
| 142 |
GRANULOCYTE COUNT DECREASED |
14 |
0.0075 |
| 143 |
DYSPLASIA |
9 |
0.0075 |
| 144 |
CEREBRAL TOXOPLASMOSIS |
7 |
0.0075 |
| 145 |
HERPES ZOSTER DISSEMINATED |
6 |
0.0075 |
| 146 |
INFUSION SITE INDURATION |
11 |
0.0074 |
| 147 |
SECONDARY IMMUNODEFICIENCY |
9 |
0.0074 |
| 148 |
NEUTROPENIC INFECTION |
7 |
0.0073 |
| 149 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
71 |
0.0071 |
| 150 |
PRINZMETAL ANGINA |
7 |
0.0070 |
| 151 |
ORTHOSTATIC INTOLERANCE |
5 |
0.0070 |
| 152 |
PANCYTOPENIA |
386 |
0.0069 |
| 153 |
METASTASIS |
49 |
0.0069 |
| 154 |
INFUSION SITE DISCOLOURATION |
6 |
0.0068 |
| 155 |
ABDOMINAL SEPSIS |
6 |
0.0068 |
| 156 |
CRYPTOCOCCOSIS |
11 |
0.0067 |
| 157 |
BLISTER RUPTURE |
5 |
0.0067 |
| 158 |
URINARY TRACT INFECTION BACTERIAL |
17 |
0.0067 |
| 159 |
APLASIA |
13 |
0.0066 |
| 160 |
DERMATITIS EXFOLIATIVE GENERALISED |
23 |
0.0066 |
| 161 |
VASCULITIC RASH |
5 |
0.0065 |
| 162 |
BLOOD BILIRUBIN DECREASED |
4 |
0.0065 |
| 163 |
NEUTROPENIC SEPSIS |
46 |
0.0064 |
| 164 |
VASCULAR PAIN |
6 |
0.0063 |
| 165 |
LYMPHOPENIA |
89 |
0.0063 |
| 166 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
14 |
0.0063 |
| 167 |
BACTERAEMIA |
74 |
0.0062 |
| 168 |
THERAPY PARTIAL RESPONDER |
97 |
0.0062 |
| 169 |
HAEMATOTOXICITY |
59 |
0.0062 |
| 170 |
RHEUMATOID NODULE |
17 |
0.0062 |
| 171 |
INFUSION SITE PAIN |
79 |
0.0061 |
| 172 |
ACUTE MYELOID LEUKAEMIA |
95 |
0.0061 |
| 173 |
INFUSION SITE OEDEMA |
5 |
0.0060 |
| 174 |
JC POLYOMAVIRUS TEST POSITIVE |
7 |
0.0060 |
| 175 |
BRONCHOPULMONARY ASPERGILLOSIS |
46 |
0.0059 |
| 176 |
HAEMOLYTIC ANAEMIA |
53 |
0.0059 |
| 177 |
PSEUDOMEMBRANOUS COLITIS |
13 |
0.0058 |
| 178 |
ENTEROVIRUS INFECTION |
5 |
0.0058 |
| 179 |
NEUROLOGICAL SYMPTOM |
33 |
0.0058 |
| 180 |
SERUM SICKNESS |
16 |
0.0057 |
| 181 |
BONE MARROW FAILURE |
115 |
0.0057 |
| 182 |
LYMPHOMA |
87 |
0.0056 |
| 183 |
VENOOCCLUSIVE DISEASE |
14 |
0.0056 |
| 184 |
CHYLOTHORAX |
4 |
0.0055 |
| 185 |
ADENOCARCINOMA GASTRIC |
5 |
0.0054 |
| 186 |
ENTEROCOCCAL INFECTION |
26 |
0.0054 |
| 187 |
ASPERGILLOSIS |
7 |
0.0054 |
| 188 |
FEAR OF INJECTION |
38 |
0.0053 |
| 189 |
DEBRIDEMENT |
4 |
0.0052 |
| 190 |
NEPHROGENIC DIABETES INSIPIDUS |
6 |
0.0052 |
| 191 |
STAPHYLOCOCCAL BACTERAEMIA |
22 |
0.0051 |
| 192 |
RASH MORBILLIFORM |
14 |
0.0050 |
| 193 |
RASH MACULO-PAPULAR |
111 |
0.0050 |
| 194 |
HEPATITIS B |
30 |
0.0050 |
| 195 |
POST HERPETIC NEURALGIA |
7 |
0.0049 |
| 196 |
VENOOCCLUSIVE LIVER DISEASE |
24 |
0.0049 |
| 197 |
DISEASE PROGRESSION |
572 |
0.0048 |
| 198 |
INFUSION SITE DISCOMFORT |
5 |
0.0048 |
| 199 |
END STAGE RENAL DISEASE |
88 |
0.0048 |
| 200 |
GIANT CELL ARTERITIS |
4 |
0.0048 |
| 201 |
SQUAMOUS CELL CARCINOMA |
45 |
0.0048 |
| 202 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
11 |
0.0047 |
| 203 |
NEOPLASM RECURRENCE |
16 |
0.0047 |
| 204 |
FEBRILE BONE MARROW APLASIA |
20 |
0.0047 |
| 205 |
HYPERCALCAEMIA |
58 |
0.0047 |
| 206 |
BACTERIAL SEPSIS |
15 |
0.0046 |
| 207 |
STREPTOCOCCAL BACTERAEMIA |
5 |
0.0046 |
| 208 |
ACARODERMATITIS |
5 |
0.0046 |
| 209 |
LISTERIOSIS |
5 |
0.0045 |
| 210 |
HYPERLEUKOCYTOSIS |
4 |
0.0045 |
| 211 |
EPSTEIN-BARR VIRAEMIA |
5 |
0.0045 |
| 212 |
CYTOKINE RELEASE SYNDROME |
90 |
0.0045 |
| 213 |
SQUAMOUS CELL CARCINOMA OF SKIN |
27 |
0.0045 |
| 214 |
INFUSION SITE SWELLING |
28 |
0.0044 |
| 215 |
KLEBSIELLA SEPSIS |
5 |
0.0044 |
| 216 |
SYSTEMIC CANDIDA |
11 |
0.0044 |
| 217 |
LOBAR PNEUMONIA |
8 |
0.0043 |
| 218 |
PNEUMONIA FUNGAL |
17 |
0.0043 |
| 219 |
H1N1 INFLUENZA |
6 |
0.0043 |
| 220 |
HYDRONEPHROSIS |
32 |
0.0043 |
| 221 |
SKIN NECROSIS |
22 |
0.0042 |
| 222 |
MYOSITIS |
38 |
0.0042 |
| 223 |
PNEUMONIA INFLUENZAL |
5 |
0.0042 |
| 224 |
UPPER RESPIRATORY TRACT INFLAMMATION |
5 |
0.0042 |
| 225 |
GASTROINTESTINAL TOXICITY |
20 |
0.0042 |
| 226 |
PLATELET COUNT DECREASED |
442 |
0.0041 |
| 227 |
ADENOVIRUS INFECTION |
12 |
0.0041 |
| 228 |
RED BLOOD CELL COUNT ABNORMAL |
6 |
0.0041 |
| 229 |
BREATH SOUNDS ABNORMAL |
20 |
0.0041 |
| 230 |
PARESIS |
9 |
0.0040 |
| 231 |
ADENOCARCINOMA |
9 |
0.0040 |
| 232 |
ADMINISTRATION SITE EXTRAVASATION |
4 |
0.0040 |
| 233 |
KLEBSIELLA INFECTION |
20 |
0.0040 |
| 234 |
INFUSION RELATED REACTION |
262 |
0.0039 |
| 235 |
PERIPHERAL SENSORY NEUROPATHY |
23 |
0.0039 |
| 236 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
15 |
0.0039 |
| 237 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
23 |
0.0039 |
| 238 |
RED CELL DISTRIBUTION WIDTH INCREASED |
16 |
0.0038 |
| 239 |
BASAL CELL CARCINOMA |
60 |
0.0038 |
| 240 |
ERYSIPELAS |
19 |
0.0038 |
| 241 |
PLASMACYTOMA |
7 |
0.0038 |
| 242 |
ADENOCARCINOMA OF COLON |
7 |
0.0037 |
| 243 |
IMMUNE THROMBOCYTOPENIA |
17 |
0.0037 |
| 244 |
MALIGNANT NEOPLASM PROGRESSION |
380 |
0.0037 |
| 245 |
NEUTROPENIA |
501 |
0.0037 |
| 246 |
LYMPHADENOPATHY |
130 |
0.0037 |
| 247 |
ASPERGILLUS INFECTION |
24 |
0.0037 |
| 248 |
HYPERURICAEMIA |
15 |
0.0036 |
| 249 |
ENTEROCOLITIS |
21 |
0.0036 |
| 250 |
PSEUDOMONAS INFECTION |
31 |
0.0036 |
| 251 |
STEVENS-JOHNSON SYNDROME |
80 |
0.0036 |
| 252 |
PERIPHERAL MOTOR NEUROPATHY |
5 |
0.0036 |
| 253 |
CLOSTRIDIAL INFECTION |
12 |
0.0035 |
| 254 |
ESCHERICHIA URINARY TRACT INFECTION |
15 |
0.0035 |
| 255 |
DIFFUSE ALVEOLAR DAMAGE |
4 |
0.0035 |
| 256 |
ACUTE SINUSITIS |
6 |
0.0035 |
| 257 |
CYSTITIS HAEMORRHAGIC |
14 |
0.0035 |
| 258 |
ILEUS |
43 |
0.0035 |
| 259 |
APLASTIC ANAEMIA |
18 |
0.0034 |
| 260 |
SPINAL CORD INJURY |
6 |
0.0034 |
| 261 |
MULTIPLE MYELOMA |
16 |
0.0034 |
| 262 |
MENINGITIS CRYPTOCOCCAL |
6 |
0.0034 |
| 263 |
HYPERTHERMIA |
26 |
0.0034 |
| 264 |
PNEUMONIA PNEUMOCOCCAL |
5 |
0.0034 |
| 265 |
EOSINOPHILIA |
59 |
0.0034 |
| 266 |
HAEMOLYSIS |
26 |
0.0034 |
| 267 |
DRUG TOLERANCE |
17 |
0.0034 |
| 268 |
SPLENOMEGALY |
39 |
0.0033 |
| 269 |
SUSPECTED OFF LABEL USE |
15 |
0.0033 |
| 270 |
GUILLAIN-BARRE SYNDROME |
16 |
0.0033 |
| 271 |
THROMBOCYTOPENIA |
367 |
0.0033 |
| 272 |
PNEUMONIA BACTERIAL |
30 |
0.0033 |
| 273 |
LYMPHOCYTOSIS |
7 |
0.0032 |
| 274 |
WHITE BLOOD CELL COUNT DECREASED |
352 |
0.0032 |
| 275 |
STAPHYLOCOCCAL SEPSIS |
16 |
0.0032 |
| 276 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED |
4 |
0.0032 |
| 277 |
INFUSION SITE ERYTHEMA |
27 |
0.0032 |
| 278 |
DISSEMINATED INTRAVASCULAR COAGULATION |
45 |
0.0032 |
| 279 |
NEUTROPHIL COUNT ABNORMAL |
9 |
0.0032 |
| 280 |
OSTEOSCLEROSIS |
5 |
0.0032 |
| 281 |
IDIOPATHIC THROMBOCYTOPENIC PURPURA |
5 |
0.0032 |
| 282 |
DRUG ERUPTION |
56 |
0.0032 |
| 283 |
BLOOD URIC ACID INCREASED |
18 |
0.0031 |
| 284 |
VASCULITIS |
36 |
0.0031 |
| 285 |
RHINOVIRUS INFECTION |
12 |
0.0031 |
| 286 |
PLASMA CELL MYELOMA RECURRENT |
10 |
0.0031 |
| 287 |
TOXIC SKIN ERUPTION |
31 |
0.0031 |
| 288 |
LYMPHOCYTE COUNT INCREASED |
10 |
0.0031 |
| 289 |
SEPTIC SHOCK |
133 |
0.0031 |
| 290 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
4 |
0.0030 |
| 291 |
AGRANULOCYTOSIS |
56 |
0.0030 |
| 292 |
GASTROENTERITIS NOROVIRUS |
4 |
0.0030 |
| 293 |
DERMATITIS EXFOLIATIVE |
15 |
0.0030 |
| 294 |
DEVICE RELATED SEPSIS |
6 |
0.0030 |
| 295 |
ESCHERICHIA BACTERAEMIA |
7 |
0.0030 |
| 296 |
BLOOD COUNT ABNORMAL |
45 |
0.0030 |
| 297 |
RHEUMATOID FACTOR POSITIVE |
17 |
0.0029 |
| 298 |
TYPE IV HYPERSENSITIVITY REACTION |
8 |
0.0029 |
| 299 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
4 |
0.0029 |
| 300 |
RETINITIS |
5 |
0.0029 |
| 301 |
PSEUDOMONAL SEPSIS |
5 |
0.0029 |
| 302 |
THROMBOPHLEBITIS |
10 |
0.0028 |
| 303 |
SKIN TOXICITY |
16 |
0.0028 |
| 304 |
ATYPICAL MYCOBACTERIAL INFECTION |
4 |
0.0028 |
| 305 |
PNEUMONIA VIRAL |
9 |
0.0028 |
| 306 |
VEIN DISORDER |
14 |
0.0028 |
| 307 |
BRAIN ABSCESS |
7 |
0.0028 |
| 308 |
OESOPHAGEAL CANDIDIASIS |
11 |
0.0028 |
| 309 |
NOCARDIOSIS |
7 |
0.0027 |
| 310 |
OTITIS MEDIA |
9 |
0.0027 |
| 311 |
IMMUNOSUPPRESSION |
24 |
0.0027 |
| 312 |
BACTERIAL TEST POSITIVE |
6 |
0.0027 |
| 313 |
LUNG OPACITY |
7 |
0.0027 |
| 314 |
C-REACTIVE PROTEIN ABNORMAL |
17 |
0.0026 |
| 315 |
PLASMA CELL MYELOMA |
102 |
0.0026 |
| 316 |
UROSEPSIS |
24 |
0.0026 |
| 317 |
LICHEN PLANUS |
6 |
0.0026 |
| 318 |
BLOOD PHOSPHORUS INCREASED |
7 |
0.0026 |
| 319 |
CANDIDA INFECTION |
43 |
0.0025 |
| 320 |
FEMORAL NECK FRACTURE |
13 |
0.0025 |
| 321 |
MUCOSAL INFLAMMATION |
66 |
0.0025 |
| 322 |
NON-SMALL CELL LUNG CANCER |
12 |
0.0025 |
| 323 |
LUNG CONSOLIDATION |
7 |
0.0025 |
| 324 |
PYREXIA |
865 |
0.0025 |
| 325 |
ATELECTASIS |
24 |
0.0025 |
| 326 |
RESPIRATORY SYMPTOM |
7 |
0.0025 |
| 327 |
DIVERTICULAR PERFORATION |
5 |
0.0024 |
| 328 |
NEOPLASM PROGRESSION |
84 |
0.0024 |
| 329 |
ESCHERICHIA SEPSIS |
7 |
0.0024 |
| 330 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
18 |
0.0024 |
| 331 |
COVID-19 |
412 |
0.0023 |
| 332 |
ANAEMIA MACROCYTIC |
5 |
0.0023 |
| 333 |
ORAL DISORDER |
17 |
0.0023 |
| 334 |
NEPHROPATHY TOXIC |
26 |
0.0023 |
| 335 |
SEPSIS |
258 |
0.0023 |
| 336 |
GLOMERULAR FILTRATION RATE DECREASED |
28 |
0.0023 |
| 337 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
4 |
0.0023 |
| 338 |
CLOSTRIDIUM DIFFICILE COLITIS |
24 |
0.0023 |
| 339 |
HEPATIC FUNCTION ABNORMAL |
83 |
0.0022 |
| 340 |
INFLAMMATORY MARKER INCREASED |
11 |
0.0022 |
| 341 |
SKIN REACTION |
31 |
0.0022 |
| 342 |
METASTASES TO MENINGES |
5 |
0.0022 |
| 343 |
HYPOALBUMINAEMIA |
17 |
0.0022 |
| 344 |
VENTRICULAR HYPOKINESIA |
7 |
0.0022 |
| 345 |
HERPES ZOSTER |
125 |
0.0022 |
| 346 |
SKIN EROSION |
7 |
0.0022 |
| 347 |
GASTROINTESTINAL PERFORATION |
9 |
0.0022 |
| 348 |
LUNG INFILTRATION |
19 |
0.0021 |
| 349 |
PEMPHIGOID |
16 |
0.0021 |
| 350 |
FAILURE TO THRIVE |
11 |
0.0021 |
| 351 |
AORTIC VALVE INCOMPETENCE |
9 |
0.0021 |
| 352 |
PULMONARY TUBERCULOSIS |
9 |
0.0021 |
| 353 |
PLEURAL EFFUSION |
127 |
0.0021 |
| 354 |
ANAEMIA |
395 |
0.0021 |
| 355 |
ACUTE CORONARY SYNDROME |
17 |
0.0021 |
| 356 |
ORAL CANDIDIASIS |
27 |
0.0020 |
| 357 |
HYPOGEUSIA |
4 |
0.0020 |
| 358 |
C-REACTIVE PROTEIN INCREASED |
74 |
0.0020 |
| 359 |
NEUROPATHY PERIPHERAL |
193 |
0.0020 |
| 360 |
HYPERBILIRUBINAEMIA |
21 |
0.0020 |
| 361 |
ENCEPHALITIS |
14 |
0.0020 |
| 362 |
HISTIOCYTOSIS HAEMATOPHAGIC |
6 |
0.0020 |
| 363 |
AORTIC STENOSIS |
7 |
0.0020 |
| 364 |
ATYPICAL PNEUMONIA |
6 |
0.0020 |
| 365 |
HERPES SIMPLEX |
13 |
0.0020 |
| 366 |
LEUKOPENIA |
100 |
0.0020 |
| 367 |
HYPOAESTHESIA ORAL |
30 |
0.0020 |
| 368 |
JAUNDICE CHOLESTATIC |
7 |
0.0020 |
| 369 |
INGUINAL HERNIA |
12 |
0.0020 |
| 370 |
RECURRENT CANCER |
8 |
0.0020 |
| 371 |
MENINGITIS |
13 |
0.0019 |
| 372 |
CACHEXIA |
10 |
0.0019 |
| 373 |
INTERSTITIAL LUNG DISEASE |
94 |
0.0019 |
| 374 |
GENERALISED OEDEMA |
24 |
0.0019 |
| 375 |
CAPILLARY LEAK SYNDROME |
4 |
0.0019 |
| 376 |
PERFORMANCE STATUS DECREASED |
9 |
0.0019 |
| 377 |
MUCORMYCOSIS |
5 |
0.0019 |
| 378 |
PSYCHOMOTOR SKILLS IMPAIRED |
5 |
0.0019 |
| 379 |
DRUG RESISTANCE |
49 |
0.0019 |
| 380 |
IMMUNE SYSTEM DISORDER |
25 |
0.0019 |
| 381 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
5 |
0.0019 |
| 382 |
ATRIAL FLUTTER |
15 |
0.0019 |
| 383 |
LEUKOENCEPHALOPATHY |
7 |
0.0019 |
| 384 |
HYPERTRANSAMINASAEMIA |
13 |
0.0019 |
| 385 |
HYPERLACTACIDAEMIA |
5 |
0.0019 |
| 386 |
FAECALOMA |
10 |
0.0018 |
| 387 |
DEVICE RELATED INFECTION |
28 |
0.0018 |
| 388 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
6 |
0.0018 |
| 389 |
CYTOLYTIC HEPATITIS |
6 |
0.0018 |
| 390 |
EMBOLISM |
15 |
0.0018 |
| 391 |
LUNG INFECTION |
28 |
0.0018 |
| 392 |
CARDIAC FAILURE ACUTE |
12 |
0.0018 |
| 393 |
LEFT VENTRICULAR DYSFUNCTION |
12 |
0.0018 |
| 394 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
9 |
0.0018 |
| 395 |
DERMATITIS |
37 |
0.0018 |
| 396 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
50 |
0.0018 |
| 397 |
GENERALISED ERYTHEMA |
10 |
0.0018 |
| 398 |
POLYNEUROPATHY |
21 |
0.0018 |
| 399 |
BRONCHOPNEUMONIA |
6 |
0.0018 |
| 400 |
BLOOD DISORDER |
14 |
0.0017 |
| 401 |
THROMBOTIC MICROANGIOPATHY |
17 |
0.0017 |
| 402 |
CHILLS |
204 |
0.0017 |
| 403 |
PULMONARY FIBROSIS |
33 |
0.0017 |
| 404 |
HYPOVOLAEMIA |
10 |
0.0017 |
| 405 |
AORTIC DISSECTION |
7 |
0.0017 |
| 406 |
PNEUMONITIS |
46 |
0.0017 |
| 407 |
HEPATITIS FULMINANT |
5 |
0.0017 |
| 408 |
ATRIAL FIBRILLATION |
164 |
0.0017 |
| 409 |
PRODUCT USE IN UNAPPROVED INDICATION |
416 |
0.0017 |
| 410 |
ASPARTATE AMINOTRANSFERASE INCREASED |
89 |
0.0017 |
| 411 |
HYPOVOLAEMIC SHOCK |
8 |
0.0017 |
| 412 |
BLOOD CULTURE POSITIVE |
5 |
0.0017 |
| 413 |
BACTERIAL INFECTION |
31 |
0.0017 |
| 414 |
BONE MARROW DISORDER |
5 |
0.0017 |
| 415 |
THROMBOPHLEBITIS SUPERFICIAL |
5 |
0.0016 |
| 416 |
NONSPECIFIC REACTION |
9 |
0.0016 |
| 417 |
GLOMERULONEPHRITIS |
4 |
0.0016 |
| 418 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
18 |
0.0016 |
| 419 |
AMYLASE INCREASED |
6 |
0.0016 |
| 420 |
RASH GENERALISED |
42 |
0.0016 |
| 421 |
BLOOD PRESSURE DECREASED |
107 |
0.0016 |
| 422 |
ANGIOPATHY |
9 |
0.0016 |
| 423 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
41 |
0.0016 |
| 424 |
ESCHERICHIA INFECTION |
13 |
0.0016 |
| 425 |
TROPONIN INCREASED |
12 |
0.0016 |
| 426 |
RED BLOOD CELL COUNT DECREASED |
45 |
0.0016 |
| 427 |
NEOPLASM |
18 |
0.0016 |
| 428 |
HAEMOGLOBIN ABNORMAL |
10 |
0.0016 |
| 429 |
INFECTION |
221 |
0.0015 |
| 430 |
DEAFNESS NEUROSENSORY |
5 |
0.0015 |
| 431 |
BLOOD LACTIC ACID INCREASED |
8 |
0.0015 |
| 432 |
ULCER |
24 |
0.0015 |
| 433 |
ODYNOPHAGIA |
9 |
0.0015 |
| 434 |
CREATININE RENAL CLEARANCE DECREASED |
6 |
0.0015 |
| 435 |
ABDOMINAL MASS |
4 |
0.0015 |
| 436 |
CARDIOMYOPATHY |
22 |
0.0015 |
| 437 |
GASTROINTESTINAL INJURY |
4 |
0.0015 |
| 438 |
ANAL ABSCESS |
8 |
0.0015 |
| 439 |
BK VIRUS INFECTION |
5 |
0.0015 |
| 440 |
ALANINE AMINOTRANSFERASE INCREASED |
90 |
0.0015 |
| 441 |
HAEMATOCRIT DECREASED |
29 |
0.0015 |
| 442 |
ARTHRITIS BACTERIAL |
6 |
0.0015 |
| 443 |
TOXIC EPIDERMAL NECROLYSIS |
22 |
0.0014 |
| 444 |
HYPOXIA |
51 |
0.0014 |
| 445 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
4 |
0.0014 |
| 446 |
PNEUMONIA |
468 |
0.0014 |
| 447 |
GRANULOMA |
5 |
0.0014 |
| 448 |
RESPIRATORY FAILURE |
104 |
0.0014 |
| 449 |
ACUTE PULMONARY OEDEMA |
8 |
0.0014 |
| 450 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
78 |
0.0014 |
| 451 |
HYPERPYREXIA |
6 |
0.0014 |
| 452 |
PULMONARY TOXICITY |
10 |
0.0014 |
| 453 |
ENTERITIS |
9 |
0.0014 |
| 454 |
GRANULOCYTOPENIA |
8 |
0.0014 |
| 455 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
31 |
0.0014 |
| 456 |
ERYTHEMA MULTIFORME |
13 |
0.0014 |
| 457 |
GRAFT VERSUS HOST DISEASE |
10 |
0.0014 |
| 458 |
CHRONIC GRAFT VERSUS HOST DISEASE |
5 |
0.0014 |
| 459 |
REFUSAL OF TREATMENT BY PATIENT |
9 |
0.0014 |
| 460 |
METABOLIC DISORDER |
8 |
0.0014 |
| 461 |
OESOPHAGITIS |
15 |
0.0014 |
| 462 |
RASH PRURITIC |
74 |
0.0014 |
| 463 |
BRONCHIECTASIS |
9 |
0.0013 |
| 464 |
STOMATITIS |
81 |
0.0013 |
| 465 |
SUBDURAL HAEMATOMA |
19 |
0.0013 |
| 466 |
GENERAL PHYSICAL CONDITION ABNORMAL |
9 |
0.0013 |
| 467 |
PLATELET COUNT ABNORMAL |
8 |
0.0013 |
| 468 |
EMBOLISM VENOUS |
4 |
0.0013 |
| 469 |
DUODENITIS |
4 |
0.0013 |
| 470 |
HYPOKALAEMIA |
60 |
0.0013 |
| 471 |
OFF LABEL USE |
1135 |
0.0013 |
| 472 |
HEPATITIS |
33 |
0.0013 |
| 473 |
OLIGURIA |
8 |
0.0013 |
| 474 |
BLOOD TEST ABNORMAL |
18 |
0.0013 |
| 475 |
EPSTEIN-BARR VIRUS INFECTION |
8 |
0.0013 |
| 476 |
RASH |
558 |
0.0013 |
| 477 |
ANURIA |
11 |
0.0013 |
| 478 |
IMMUNODEFICIENCY |
19 |
0.0013 |
| 479 |
STAPHYLOCOCCAL INFECTION |
42 |
0.0013 |
| 480 |
VENTRICULAR TACHYCARDIA |
21 |
0.0013 |
| 481 |
THERAPY NON-RESPONDER |
57 |
0.0013 |
| 482 |
LIVER DISORDER |
56 |
0.0013 |
| 483 |
ASCITES |
37 |
0.0013 |
| 484 |
STREPTOCOCCAL INFECTION |
7 |
0.0013 |
| 485 |
SUPRAVENTRICULAR TACHYCARDIA |
12 |
0.0013 |
| 486 |
MALNUTRITION |
14 |
0.0013 |
| 487 |
TACHYPNOEA |
17 |
0.0012 |
| 488 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
22 |
0.0012 |
| 489 |
ORGAN FAILURE |
5 |
0.0012 |
| 490 |
NODULE |
16 |
0.0012 |
| 491 |
RENAL TUBULAR NECROSIS |
12 |
0.0012 |
| 492 |
HERPES VIRUS INFECTION |
7 |
0.0012 |
| 493 |
PATHOGEN RESISTANCE |
11 |
0.0012 |
| 494 |
ACUTE KIDNEY INJURY |
184 |
0.0012 |
| 495 |
HYPOTONIA |
12 |
0.0012 |
| 496 |
EOSINOPHIL COUNT INCREASED |
10 |
0.0012 |
| 497 |
NEUROTOXICITY |
21 |
0.0012 |
| 498 |
COLITIS |
45 |
0.0012 |
| 499 |
COLITIS ISCHAEMIC |
8 |
0.0012 |
| 500 |
HEPATIC ENCEPHALOPATHY |
11 |
0.0012 |
| 501 |
GOUT |
21 |
0.0012 |
| 502 |
APHTHOUS ULCER |
9 |
0.0012 |
| 503 |
INTESTINAL PERFORATION |
13 |
0.0012 |
| 504 |
RESPIRATORY TRACT INFECTION |
30 |
0.0012 |
| 505 |
HYPOMAGNESAEMIA |
16 |
0.0011 |
| 506 |
ACUTE RESPIRATORY FAILURE |
22 |
0.0011 |
| 507 |
VIRAL INFECTION |
38 |
0.0011 |
| 508 |
POLYARTHRITIS |
6 |
0.0011 |
| 509 |
RESPIRATORY DISTRESS |
31 |
0.0011 |
| 510 |
DECREASED IMMUNE RESPONSIVENESS |
11 |
0.0011 |
| 511 |
RASH PAPULAR |
25 |
0.0011 |
| 512 |
MENINGITIS ASEPTIC |
5 |
0.0011 |
| 513 |
HAEMOGLOBIN DECREASED |
114 |
0.0011 |
| 514 |
BONE LESION |
4 |
0.0011 |
| 515 |
VASCULAR DEVICE INFECTION |
5 |
0.0011 |
| 516 |
HEPATIC CYTOLYSIS |
14 |
0.0011 |
| 517 |
CUTANEOUS VASCULITIS |
4 |
0.0011 |
| 518 |
ACUTE GRAFT VERSUS HOST DISEASE |
5 |
0.0011 |
| 519 |
RASH ERYTHEMATOUS |
52 |
0.0011 |
| 520 |
BLOOD CREATININE INCREASED |
70 |
0.0011 |
| 521 |
CHRONIC SINUSITIS |
4 |
0.0011 |
| 522 |
SARS-COV-2 TEST POSITIVE |
14 |
0.0011 |
| 523 |
CARDIAC TAMPONADE |
5 |
0.0011 |
| 524 |
HYPOTENSION |
211 |
0.0011 |
| 525 |
LEUKOCYTOSIS |
19 |
0.0010 |
| 526 |
RENAL IMPAIRMENT |
88 |
0.0010 |
| 527 |
MYOCARDITIS |
12 |
0.0010 |
| 528 |
SUBCUTANEOUS ABSCESS |
5 |
0.0010 |
| 529 |
CHOLESTASIS |
20 |
0.0010 |
| 530 |
SUDDEN DEATH |
11 |
0.0010 |
| 531 |
METASTASES TO LYMPH NODES |
7 |
0.0010 |
| 532 |
BLOOD BILIRUBIN INCREASED |
28 |
0.0010 |
| 533 |
EJECTION FRACTION DECREASED |
16 |
0.0010 |
| 534 |
BODY TEMPERATURE INCREASED |
21 |
0.0010 |
| 535 |
CARDIOTOXICITY |
9 |
0.0010 |
| 536 |
FACE OEDEMA |
17 |
0.0010 |
| 537 |
GENERAL PHYSICAL HEALTH DETERIORATION |
116 |
0.0010 |
| 538 |
AZOTAEMIA |
4 |
0.0010 |
| 539 |
PNEUMONIA ASPIRATION |
25 |
0.0010 |
| 540 |
CANDIDIASIS |
4 |
0.0010 |
| 541 |
PRODUCT USE ISSUE |
187 |
0.0010 |
| 542 |
PERICARDIAL EFFUSION |
23 |
0.0010 |
| 543 |
FUNGAL INFECTION |
33 |
0.0010 |
| 544 |
DISORIENTATION |
39 |
0.0010 |
| 545 |
DEMYELINATION |
4 |
0.0010 |
| 546 |
TUBULOINTERSTITIAL NEPHRITIS |
18 |
0.0010 |
| 547 |
METASTASES TO LUNG |
11 |
0.0010 |
| 548 |
HYPOCALCAEMIA |
18 |
0.0010 |
| 549 |
SKIN LESION |
26 |
0.0009 |
| 550 |
INTENTIONAL PRODUCT USE ISSUE |
83 |
0.0009 |
| 551 |
SYNOVITIS |
17 |
0.0009 |
| 552 |
RENAL FAILURE ACUTE |
40 |
0.0009 |
| 553 |
ANAPHYLACTIC REACTION |
52 |
0.0009 |
| 554 |
WHITE BLOOD CELL COUNT ABNORMAL |
6 |
0.0009 |
| 555 |
INCORRECT DRUG ADMINISTRATION RATE |
4 |
0.0009 |
| 556 |
CARDIAC FAILURE CHRONIC |
4 |
0.0009 |
| 557 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
12 |
0.0009 |
| 558 |
MYOPATHY |
8 |
0.0009 |
| 559 |
MULTI-ORGAN FAILURE |
16 |
0.0009 |
| 560 |
DEHYDRATION |
123 |
0.0009 |
| 561 |
SINUS TACHYCARDIA |
13 |
0.0009 |
| 562 |
WHITE BLOOD CELL COUNT INCREASED |
35 |
0.0009 |
| 563 |
ANKYLOSING SPONDYLITIS |
12 |
0.0009 |
| 564 |
ADRENAL INSUFFICIENCY |
11 |
0.0009 |
| 565 |
PURPURA |
8 |
0.0009 |
| 566 |
NECROSIS |
5 |
0.0009 |
| 567 |
LIVER FUNCTION TEST ABNORMAL |
26 |
0.0009 |
| 568 |
SMALL INTESTINAL OBSTRUCTION |
11 |
0.0009 |
| 569 |
REBOUND EFFECT |
10 |
0.0009 |
| 570 |
PNEUMOTHORAX |
14 |
0.0009 |
| 571 |
PERONEAL NERVE PALSY |
5 |
0.0009 |
| 572 |
PULMONARY MASS |
13 |
0.0009 |
| 573 |
CLOSTRIDIUM DIFFICILE INFECTION |
19 |
0.0009 |
| 574 |
SKIN DISORDER |
29 |
0.0009 |
| 575 |
PETECHIAE |
9 |
0.0009 |
| 576 |
ELECTROLYTE IMBALANCE |
10 |
0.0009 |
| 577 |
JAUNDICE |
23 |
0.0009 |
| 578 |
METASTASES TO LIVER |
15 |
0.0009 |
| 579 |
ANAPHYLACTIC SHOCK |
22 |
0.0009 |
| 580 |
PULMONARY EMBOLISM |
81 |
0.0009 |
| 581 |
HEPATIC CIRRHOSIS |
16 |
0.0009 |
| 582 |
SPINAL COMPRESSION FRACTURE |
7 |
0.0008 |
| 583 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
21 |
0.0008 |
| 584 |
DISEASE RECURRENCE |
40 |
0.0008 |
| 585 |
HYPERSENSITIVITY |
156 |
0.0008 |
| 586 |
CHOLECYSTITIS |
10 |
0.0008 |
| 587 |
DELIRIUM |
29 |
0.0008 |
| 588 |
HEPATIC FAILURE |
25 |
0.0008 |
| 589 |
CARDIAC FAILURE |
66 |
0.0008 |
| 590 |
ENCEPHALOPATHY |
20 |
0.0008 |
| 591 |
DECREASED APPETITE |
189 |
0.0008 |
| 592 |
INJECTION SITE EXTRAVASATION |
10 |
0.0008 |
| 593 |
CONJUNCTIVITIS |
15 |
0.0008 |
| 594 |
HEPATOTOXICITY |
18 |
0.0008 |
| 595 |
PYELONEPHRITIS |
7 |
0.0008 |
| 596 |
ACUTE HEPATIC FAILURE |
11 |
0.0008 |
| 597 |
ORTHOSTATIC HYPOTENSION |
14 |
0.0008 |
| 598 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
7 |
0.0008 |
| 599 |
HYPERNATRAEMIA |
4 |
0.0008 |
| 600 |
SKIN INFECTION |
9 |
0.0008 |
| 601 |
FLUID INTAKE REDUCED |
4 |
0.0008 |
| 602 |
CELLULITIS |
40 |
0.0008 |
| 603 |
THERAPEUTIC RESPONSE DECREASED |
48 |
0.0008 |
| 604 |
HYPOPHAGIA |
20 |
0.0008 |
| 605 |
NEUTROPHIL COUNT INCREASED |
8 |
0.0008 |
| 606 |
CARDIAC DISORDER |
73 |
0.0008 |
| 607 |
ACUTE MYOCARDIAL INFARCTION |
23 |
0.0008 |
| 608 |
ENDOCARDITIS |
4 |
0.0008 |
| 609 |
CEREBRAL ISCHAEMIA |
4 |
0.0008 |
| 610 |
VENTRICULAR EXTRASYSTOLES |
8 |
0.0008 |
| 611 |
TENDERNESS |
8 |
0.0008 |
| 612 |
TACHYCARDIA |
68 |
0.0008 |
| 613 |
CIRCULATORY COLLAPSE |
13 |
0.0008 |
| 614 |
TREATMENT FAILURE |
63 |
0.0008 |
| 615 |
OEDEMA |
41 |
0.0008 |
| 616 |
GASTROENTERITIS |
11 |
0.0008 |
| 617 |
RENAL FAILURE |
100 |
0.0008 |
| 618 |
ERYTHEMA |
154 |
0.0007 |
| 619 |
MALIGNANT MELANOMA |
10 |
0.0007 |
| 620 |
FULL BLOOD COUNT DECREASED |
15 |
0.0007 |
| 621 |
HYPERKALAEMIA |
26 |
0.0007 |
| 622 |
SKIN ULCER |
19 |
0.0007 |
| 623 |
HICCUPS |
6 |
0.0007 |
| 624 |
ISCHAEMIC STROKE |
13 |
0.0007 |
| 625 |
DRUG LEVEL BELOW THERAPEUTIC |
4 |
0.0007 |
| 626 |
BRONCHITIS |
53 |
0.0007 |
| 627 |
HAEMODIALYSIS |
6 |
0.0007 |
| 628 |
LUNG DISORDER |
35 |
0.0007 |
| 629 |
BLINDNESS |
29 |
0.0007 |
| 630 |
PSYCHOTIC DISORDER |
21 |
0.0007 |
| 631 |
INFLAMMATION |
36 |
0.0007 |
| 632 |
SHOCK |
16 |
0.0007 |
| 633 |
ALTERED STATE OF CONSCIOUSNESS |
15 |
0.0007 |
| 634 |
PULMONARY OEDEMA |
31 |
0.0007 |
| 635 |
SKIN SWELLING |
6 |
0.0007 |
| 636 |
CYSTITIS |
22 |
0.0007 |
| 637 |
HYPERVENTILATION |
4 |
0.0007 |
| 638 |
DRUG EFFECT INCOMPLETE |
25 |
0.0007 |
| 639 |
RASH PUSTULAR |
5 |
0.0007 |
| 640 |
RASH MACULAR |
24 |
0.0007 |
| 641 |
HYPOPHOSPHATAEMIA |
5 |
0.0007 |
| 642 |
ATAXIA |
8 |
0.0007 |
| 643 |
COLON CANCER |
10 |
0.0007 |
| 644 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
35 |
0.0007 |
| 645 |
HEPATITIS CHOLESTATIC |
4 |
0.0007 |
| 646 |
BLOOD UREA INCREASED |
11 |
0.0007 |
| 647 |
NO THERAPEUTIC RESPONSE |
8 |
0.0007 |
| 648 |
LIPASE INCREASED |
5 |
0.0007 |
| 649 |
HEMIPARESIS |
11 |
0.0006 |
| 650 |
FLANK PAIN |
6 |
0.0006 |
| 651 |
INTESTINAL OBSTRUCTION |
24 |
0.0006 |
| 652 |
DERMATITIS ALLERGIC |
8 |
0.0006 |
| 653 |
LEUKAEMIA |
6 |
0.0006 |
| 654 |
VENTRICULAR FIBRILLATION |
7 |
0.0006 |
| 655 |
TRANSAMINASES INCREASED |
14 |
0.0006 |
| 656 |
URINARY RETENTION |
21 |
0.0006 |
| 657 |
TRICUSPID VALVE INCOMPETENCE |
5 |
0.0006 |
| 658 |
PULMONARY HYPERTENSION |
13 |
0.0006 |
| 659 |
SINUS BRADYCARDIA |
6 |
0.0006 |
| 660 |
PRESCRIBED OVERDOSE |
12 |
0.0006 |
| 661 |
SYNCOPE |
62 |
0.0006 |
| 662 |
MITRAL VALVE INCOMPETENCE |
7 |
0.0006 |
| 663 |
CEREBRAL INFARCTION |
15 |
0.0006 |
| 664 |
DIVERTICULITIS |
17 |
0.0006 |
| 665 |
HAEMATURIA |
21 |
0.0006 |
| 666 |
LIVER INJURY |
15 |
0.0006 |
| 667 |
FLUSHING |
62 |
0.0006 |
| 668 |
CHOLELITHIASIS |
20 |
0.0006 |
| 669 |
NERVOUS SYSTEM DISORDER |
19 |
0.0006 |
| 670 |
DEEP VEIN THROMBOSIS |
39 |
0.0006 |
| 671 |
EMPHYSEMA |
6 |
0.0006 |
| 672 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
10 |
0.0006 |
| 673 |
MELAENA |
13 |
0.0006 |
| 674 |
DRUG LEVEL DECREASED |
6 |
0.0006 |
| 675 |
SUBARACHNOID HAEMORRHAGE |
6 |
0.0006 |
| 676 |
CARDIAC ARREST |
48 |
0.0006 |
| 677 |
MENTAL STATUS CHANGES |
16 |
0.0006 |
| 678 |
ASTHENIA |
216 |
0.0006 |
| 679 |
URINE OUTPUT DECREASED |
5 |
0.0006 |
| 680 |
ARRHYTHMIA |
27 |
0.0006 |
| 681 |
BLINDNESS UNILATERAL |
8 |
0.0006 |
| 682 |
ABSCESS |
9 |
0.0006 |
| 683 |
BLOOD PRESSURE SYSTOLIC INCREASED |
11 |
0.0006 |
| 684 |
ORAL HERPES |
11 |
0.0006 |
| 685 |
PEMPHIGUS |
7 |
0.0006 |
| 686 |
GASTROINTESTINAL INFECTION |
5 |
0.0006 |
| 687 |
DECREASED ACTIVITY |
6 |
0.0006 |
| 688 |
DERMATITIS BULLOUS |
4 |
0.0006 |
| 689 |
HYPERGLYCAEMIA |
20 |
0.0005 |
| 690 |
DRUG INTOLERANCE |
52 |
0.0005 |
| 691 |
APPENDICITIS |
5 |
0.0005 |
| 692 |
HAEMORRHAGE INTRACRANIAL |
8 |
0.0005 |
| 693 |
ABDOMINAL PAIN |
124 |
0.0005 |
| 694 |
CEREBRAL HAEMORRHAGE |
19 |
0.0005 |
| 695 |
PANCREATITIS |
28 |
0.0005 |
| 696 |
CONSTIPATION |
115 |
0.0005 |
| 697 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
5 |
0.0005 |
| 698 |
DIARRHOEA |
336 |
0.0005 |
| 699 |
ATRIOVENTRICULAR BLOCK |
4 |
0.0005 |
| 700 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
4 |
0.0005 |
| 701 |
HEPATIC ENZYME INCREASED |
35 |
0.0005 |
| 702 |
VITREOUS FLOATERS |
5 |
0.0005 |
| 703 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
36 |
0.0005 |
| 704 |
DYSARTHRIA |
19 |
0.0005 |
| 705 |
FEELING COLD |
14 |
0.0005 |
| 706 |
HEPATOCELLULAR INJURY |
7 |
0.0005 |
| 707 |
DEATH |
425 |
0.0005 |
| 708 |
TASTE DISORDER |
10 |
0.0005 |
| 709 |
EYELID PTOSIS |
5 |
0.0005 |
| 710 |
TOOTH ABSCESS |
5 |
0.0005 |
| 711 |
MOTOR DYSFUNCTION |
5 |
0.0005 |
| 712 |
PANCREATITIS ACUTE |
11 |
0.0005 |
| 713 |
CARDIOGENIC SHOCK |
7 |
0.0005 |
| 714 |
CARDIOMEGALY |
6 |
0.0005 |
| 715 |
PRODUCT PREPARATION ERROR |
10 |
0.0005 |
| 716 |
INFLUENZA |
54 |
0.0005 |
| 717 |
OEDEMA PERIPHERAL |
59 |
0.0005 |
| 718 |
PERITONITIS |
10 |
0.0005 |
| 719 |
TOOTH EXTRACTION |
6 |
0.0005 |
| 720 |
MOUTH ULCERATION |
10 |
0.0005 |
| 721 |
LABORATORY TEST ABNORMAL |
14 |
0.0005 |
| 722 |
VOMITING |
223 |
0.0005 |
| 723 |
FULL BLOOD COUNT ABNORMAL |
5 |
0.0005 |
| 724 |
ELECTROCARDIOGRAM QT PROLONGED |
17 |
0.0005 |
| 725 |
RENAL DISORDER |
22 |
0.0005 |
| 726 |
NAUSEA |
373 |
0.0005 |
| 727 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
21 |
0.0005 |
| 728 |
CONFUSIONAL STATE |
75 |
0.0005 |
| 729 |
BLOOD MAGNESIUM DECREASED |
4 |
0.0005 |
| 730 |
HAEMATOMA |
12 |
0.0005 |
| 731 |
BLISTER |
26 |
0.0005 |
| 732 |
DEAFNESS |
12 |
0.0005 |
| 733 |
LOCAL SWELLING |
8 |
0.0005 |
| 734 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
22 |
0.0005 |
| 735 |
BURNING SENSATION |
32 |
0.0005 |
| 736 |
GROIN PAIN |
4 |
0.0005 |
| 737 |
UPPER RESPIRATORY TRACT INFECTION |
21 |
0.0005 |
| 738 |
COUGH |
127 |
0.0005 |
| 739 |
DYSPNOEA EXERTIONAL |
17 |
0.0005 |
| 740 |
THIRST |
8 |
0.0004 |
| 741 |
URINARY TRACT INFECTION |
76 |
0.0004 |
| 742 |
MYOCARDIAL ISCHAEMIA |
5 |
0.0004 |
| 743 |
URINARY INCONTINENCE |
13 |
0.0004 |
| 744 |
ALOPECIA |
86 |
0.0004 |
| 745 |
RESPIRATORY DISORDER |
13 |
0.0004 |
| 746 |
TOXICITY TO VARIOUS AGENTS |
73 |
0.0004 |
| 747 |
URTICARIA |
72 |
0.0004 |
| 748 |
MASS |
6 |
0.0004 |
| 749 |
HYPONATRAEMIA |
24 |
0.0004 |
| 750 |
BLOOD URINE PRESENT |
8 |
0.0004 |
| 751 |
DRY EYE |
21 |
0.0004 |
| 752 |
DYSPNOEA |
237 |
0.0004 |
| 753 |
WEIGHT DECREASED |
116 |
0.0004 |
| 754 |
DYSURIA |
15 |
0.0004 |
| 755 |
SKIN EXFOLIATION |
34 |
0.0004 |
| 756 |
BLOOD POTASSIUM DECREASED |
12 |
0.0004 |
| 757 |
FATIGUE |
308 |
0.0004 |
| 758 |
ABDOMINAL PAIN LOWER |
10 |
0.0004 |
| 759 |
HYPOTHERMIA |
4 |
0.0004 |
| 760 |
PRURITUS |
151 |
0.0004 |
| 761 |
BONE PAIN |
23 |
0.0004 |
| 762 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
4 |
0.0004 |
| 763 |
CARDIO-RESPIRATORY ARREST |
16 |
0.0004 |
| 764 |
PULMONARY CONGESTION |
5 |
0.0004 |
| 765 |
INCONTINENCE |
4 |
0.0004 |
| 766 |
LOWER RESPIRATORY TRACT INFECTION |
17 |
0.0004 |
| 767 |
OXYGEN SATURATION DECREASED |
21 |
0.0004 |
| 768 |
BREAST CANCER METASTATIC |
4 |
0.0004 |
| 769 |
NIGHT SWEATS |
12 |
0.0004 |
| 770 |
RENAL INJURY |
11 |
0.0004 |
| 771 |
FRACTURE |
7 |
0.0004 |
| 772 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
8 |
0.0004 |
| 773 |
GASTRIC ULCER |
7 |
0.0004 |
| 774 |
PROTEINURIA |
7 |
0.0004 |
| 775 |
ASPIRATION |
4 |
0.0004 |
| 776 |
ABASIA |
9 |
0.0004 |
| 777 |
GENERALISED TONIC-CLONIC SEIZURE |
6 |
0.0004 |
| 778 |
THROMBOSIS |
29 |
0.0004 |
| 779 |
HYPERTENSIVE CRISIS |
4 |
0.0004 |
| 780 |
HAEMORRHOIDS |
7 |
0.0004 |
| 781 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
13 |
0.0004 |
| 782 |
GASTROINTESTINAL DISORDER |
32 |
0.0004 |
| 783 |
KIDNEY INFECTION |
7 |
0.0004 |
| 784 |
SPINAL FRACTURE |
7 |
0.0003 |
| 785 |
PARALYSIS |
5 |
0.0003 |
| 786 |
HAEMORRHAGE |
36 |
0.0003 |
| 787 |
METABOLIC ACIDOSIS |
11 |
0.0003 |
| 788 |
APATHY |
5 |
0.0003 |
| 789 |
DRUG INEFFECTIVE |
451 |
0.0003 |
| 790 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
10 |
0.0003 |
| 791 |
BACK PAIN |
79 |
0.0003 |
| 792 |
SKIN HAEMORRHAGE |
5 |
0.0003 |
| 793 |
FLATULENCE |
19 |
0.0003 |
| 794 |
HEART RATE INCREASED |
33 |
0.0003 |
| 795 |
APHASIA |
10 |
0.0003 |
| 796 |
CONTRAINDICATED PRODUCT ADMINISTERED |
10 |
0.0003 |
| 797 |
LETHARGY |
19 |
0.0003 |
| 798 |
SUICIDE ATTEMPT |
20 |
0.0003 |
| 799 |
ILL-DEFINED DISORDER |
20 |
0.0003 |
| 800 |
PRESYNCOPE |
8 |
0.0003 |
| 801 |
EATING DISORDER |
7 |
0.0003 |
| 802 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
13 |
0.0003 |
| 803 |
DYSPHAGIA |
31 |
0.0003 |
| 804 |
ARTHROPATHY |
18 |
0.0003 |
| 805 |
ABNORMAL WEIGHT GAIN |
4 |
0.0003 |
| 806 |
HAEMOPTYSIS |
9 |
0.0003 |
| 807 |
DEMENTIA |
9 |
0.0003 |
| 808 |
CYANOSIS |
5 |
0.0003 |
| 809 |
ANGINA PECTORIS |
9 |
0.0003 |
| 810 |
CARDIAC FAILURE CONGESTIVE |
25 |
0.0003 |
| 811 |
GASTROINTESTINAL HAEMORRHAGE |
26 |
0.0003 |
| 812 |
ANOREXIA |
4 |
0.0003 |
| 813 |
BLOOD POTASSIUM INCREASED |
5 |
0.0003 |
| 814 |
TREMOR |
51 |
0.0003 |
| 815 |
SKIN FISSURES |
6 |
0.0003 |
| 816 |
ECZEMA |
16 |
0.0003 |
| 817 |
MYOCARDIAL INFARCTION |
53 |
0.0003 |
| 818 |
CHEST DISCOMFORT |
31 |
0.0003 |
| 819 |
HYPERTENSION |
64 |
0.0003 |
| 820 |
UPPER LIMB FRACTURE |
6 |
0.0003 |
| 821 |
MALAISE |
132 |
0.0003 |
| 822 |
PERICARDITIS |
5 |
0.0003 |
| 823 |
CHEST PAIN |
55 |
0.0003 |
| 824 |
GINGIVAL BLEEDING |
4 |
0.0003 |
| 825 |
ARTHRITIS |
23 |
0.0003 |
| 826 |
RESPIRATORY ARREST |
8 |
0.0003 |
| 827 |
DIABETES MELLITUS |
22 |
0.0003 |
| 828 |
CONDITION AGGRAVATED |
86 |
0.0003 |
| 829 |
BRADYCARDIA |
15 |
0.0003 |
| 830 |
RETCHING |
6 |
0.0003 |
| 831 |
MOVEMENT DISORDER |
9 |
0.0003 |
| 832 |
HYPERHIDROSIS |
36 |
0.0003 |
| 833 |
SWELLING FACE |
18 |
0.0003 |
| 834 |
GASTRIC CANCER |
7 |
0.0003 |
| 835 |
MUSCULOSKELETAL STIFFNESS |
24 |
0.0003 |
| 836 |
SINUSITIS |
28 |
0.0003 |
| 837 |
PRODUCTIVE COUGH |
13 |
0.0003 |
| 838 |
VISUAL ACUITY REDUCED |
9 |
0.0003 |
| 839 |
DIPLOPIA |
7 |
0.0003 |
| 840 |
DYSGEUSIA |
20 |
0.0003 |
| 841 |
LUNG NEOPLASM MALIGNANT |
11 |
0.0003 |
| 842 |
BLOOD SODIUM DECREASED |
5 |
0.0003 |
| 843 |
MUSCULAR WEAKNESS |
30 |
0.0003 |
| 844 |
BLOOD PRESSURE INCREASED |
40 |
0.0003 |
| 845 |
PARAESTHESIA |
41 |
0.0003 |
| 846 |
PALLOR |
7 |
0.0003 |
| 847 |
SWOLLEN TONGUE |
8 |
0.0003 |
| 848 |
PERIPHERAL SWELLING |
39 |
0.0003 |
| 849 |
HEPATIC CANCER |
6 |
0.0002 |
| 850 |
MYALGIA |
42 |
0.0002 |
| 851 |
LACTIC ACIDOSIS |
8 |
0.0002 |
| 852 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
7 |
0.0002 |
| 853 |
FLUID RETENTION |
12 |
0.0002 |
| 854 |
COGNITIVE DISORDER |
11 |
0.0002 |
| 855 |
LIVER FUNCTION TEST INCREASED |
5 |
0.0002 |
| 856 |
SKIN CANCER |
5 |
0.0002 |
| 857 |
PRURITUS GENERALISED |
5 |
0.0002 |
| 858 |
PRODUCT PRESCRIBING ISSUE |
5 |
0.0002 |
| 859 |
COLD SWEAT |
4 |
0.0002 |
| 860 |
OROPHARYNGEAL PAIN |
21 |
0.0002 |
| 861 |
ANGIOEDEMA |
10 |
0.0002 |
| 862 |
HEAD DISCOMFORT |
4 |
0.0002 |
| 863 |
EAR INFECTION |
6 |
0.0002 |
| 864 |
FALL |
75 |
0.0002 |
| 865 |
UNEVALUABLE EVENT |
17 |
0.0002 |
| 866 |
JOINT SWELLING |
27 |
0.0002 |
| 867 |
PAIN OF SKIN |
6 |
0.0002 |
| 868 |
THROAT TIGHTNESS |
6 |
0.0002 |
| 869 |
HEAD INJURY |
7 |
0.0002 |
| 870 |
LOSS OF CONSCIOUSNESS |
28 |
0.0002 |
| 871 |
SKIN DISCOLOURATION |
10 |
0.0002 |
| 872 |
NASOPHARYNGITIS |
40 |
0.0002 |
| 873 |
EYE SWELLING |
8 |
0.0002 |
| 874 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
5 |
0.0002 |
| 875 |
DRUG INTERACTION |
34 |
0.0002 |
| 876 |
FEELING HOT |
13 |
0.0002 |
| 877 |
HYPOAESTHESIA |
31 |
0.0002 |
| 878 |
NEURALGIA |
5 |
0.0002 |
| 879 |
WHEEZING |
12 |
0.0002 |
| 880 |
OSTEONECROSIS OF JAW |
5 |
0.0002 |
| 881 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
4 |
0.0002 |
| 882 |
COLITIS ULCERATIVE |
9 |
0.0002 |
| 883 |
EPILEPSY |
6 |
0.0002 |
| 884 |
LIMB DISCOMFORT |
6 |
0.0002 |
| 885 |
UNRESPONSIVE TO STIMULI |
5 |
0.0002 |
| 886 |
PAIN IN EXTREMITY |
57 |
0.0002 |
| 887 |
SWELLING |
18 |
0.0002 |
| 888 |
RHABDOMYOLYSIS |
8 |
0.0002 |
| 889 |
ABDOMINAL DISTENSION |
20 |
0.0002 |
| 890 |
ABDOMINAL DISCOMFORT |
32 |
0.0002 |
| 891 |
GASTRITIS |
5 |
0.0002 |
| 892 |
PALPITATIONS |
22 |
0.0002 |
| 893 |
INSOMNIA |
50 |
0.0002 |
| 894 |
RHEUMATOID ARTHRITIS |
21 |
0.0002 |
| 895 |
IMPAIRED HEALING |
6 |
0.0002 |
| 896 |
HAEMATOCHEZIA |
10 |
0.0002 |
| 897 |
ABNORMAL DREAMS |
5 |
0.0002 |
| 898 |
DIZZINESS |
90 |
0.0002 |
| 899 |
DISCOMFORT |
11 |
0.0002 |
| 900 |
LIP SWELLING |
6 |
0.0002 |
| 901 |
TRANSIENT ISCHAEMIC ATTACK |
6 |
0.0002 |
| 902 |
INCORRECT DRUG ADMINISTRATION DURATION |
5 |
0.0002 |
| 903 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
6 |
0.0002 |
| 904 |
CONTUSION |
17 |
0.0002 |
| 905 |
PAIN |
107 |
0.0002 |
| 906 |
HEADACHE |
109 |
0.0002 |
| 907 |
EPISTAXIS |
13 |
0.0002 |
| 908 |
DRY MOUTH |
14 |
0.0002 |
| 909 |
SPEECH DISORDER |
9 |
0.0002 |
| 910 |
CHRONIC KIDNEY DISEASE |
13 |
0.0002 |
| 911 |
HEART RATE DECREASED |
6 |
0.0002 |
| 912 |
WEIGHT INCREASED |
38 |
0.0002 |
| 913 |
UNDERDOSE |
12 |
0.0002 |
| 914 |
DYSPEPSIA |
16 |
0.0002 |
| 915 |
DEPRESSION |
37 |
0.0002 |
| 916 |
FEMUR FRACTURE |
5 |
0.0002 |
| 917 |
ARTHRALGIA |
67 |
0.0002 |
| 918 |
DRUG-INDUCED LIVER INJURY |
5 |
0.0002 |
| 919 |
HOT FLUSH |
12 |
0.0002 |
| 920 |
CARDIOVASCULAR DISORDER |
4 |
0.0002 |
| 921 |
HYPOTHYROIDISM |
5 |
0.0002 |
| 922 |
THERAPY CESSATION |
8 |
0.0002 |
| 923 |
BLADDER CANCER |
9 |
0.0002 |
| 924 |
DISTURBANCE IN ATTENTION |
8 |
0.0001 |
| 925 |
POLLAKIURIA |
6 |
0.0001 |
| 926 |
ABDOMINAL PAIN UPPER |
29 |
0.0001 |
| 927 |
RHINORRHOEA |
9 |
0.0001 |
| 928 |
DYSSTASIA |
4 |
0.0001 |
| 929 |
PROSTATE CANCER |
11 |
0.0001 |
| 930 |
MUSCLE SPASMS |
25 |
0.0001 |
| 931 |
INJECTION SITE MASS |
5 |
0.0001 |
| 932 |
THROAT IRRITATION |
6 |
0.0001 |
| 933 |
MUSCULOSKELETAL PAIN |
7 |
0.0001 |
| 934 |
CORONARY ARTERY DISEASE |
4 |
0.0001 |
| 935 |
VERTIGO |
8 |
0.0001 |
| 936 |
NEPHROLITHIASIS |
6 |
0.0001 |
| 937 |
INJECTION SITE REACTION |
9 |
0.0001 |
| 938 |
TINNITUS |
6 |
0.0001 |
| 939 |
COMA |
6 |
0.0001 |
| 940 |
NECK PAIN |
7 |
0.0001 |
| 941 |
HYPOGLYCAEMIA |
6 |
0.0001 |
| 942 |
AMNESIA |
8 |
0.0001 |
| 943 |
AGITATION |
9 |
0.0001 |
| 944 |
EYE DISORDER |
4 |
0.0001 |
| 945 |
SEIZURE |
14 |
0.0001 |
| 946 |
INJECTION SITE PAIN |
37 |
0.0001 |
| 947 |
GAIT DISTURBANCE |
23 |
0.0001 |
| 948 |
DRY SKIN |
16 |
0.0001 |
| 949 |
NEOPLASM MALIGNANT |
8 |
0.0001 |
| 950 |
DYSPHONIA |
7 |
0.0001 |
| 951 |
ADVERSE EVENT |
11 |
0.0001 |
| 952 |
NASAL CONGESTION |
7 |
0.0001 |
| 953 |
OSTEOARTHRITIS |
5 |
0.0001 |
| 954 |
CATARACT |
7 |
0.0001 |
| 955 |
CEREBROVASCULAR ACCIDENT |
19 |
0.0001 |
| 956 |
GASTROOESOPHAGEAL REFLUX DISEASE |
9 |
0.0001 |
| 957 |
BLOOD GLUCOSE INCREASED |
21 |
0.0001 |
| 958 |
MOBILITY DECREASED |
8 |
0.0001 |
| 959 |
CONVULSION |
6 |
0.0001 |
| 960 |
VISUAL IMPAIRMENT |
13 |
0.0001 |
| 961 |
ABNORMAL BEHAVIOUR |
4 |
0.0001 |
| 962 |
THERAPY INTERRUPTED |
7 |
0.0001 |
| 963 |
HALLUCINATION |
7 |
0.0001 |
| 964 |
ACNE |
7 |
0.0001 |
| 965 |
NO ADVERSE EVENT |
16 |
0.0001 |
| 966 |
FEELING ABNORMAL |
21 |
0.0001 |
| 967 |
ACCIDENTAL EXPOSURE TO PRODUCT |
9 |
0.0001 |
| 968 |
EYE IRRITATION |
5 |
0.0001 |
| 969 |
BLOOD GLUCOSE DECREASED |
4 |
0.0001 |
| 970 |
BALANCE DISORDER |
7 |
0.0001 |
| 971 |
MEMORY IMPAIRMENT |
11 |
0.0001 |
| 972 |
INTENTIONAL OVERDOSE |
5 |
0.0001 |
| 973 |
SOMNOLENCE |
15 |
0.0001 |
| 974 |
ANXIETY |
21 |
0.0001 |
| 975 |
ADVERSE DRUG REACTION |
6 |
0.0001 |
| 976 |
HOSPITALISATION |
10 |
0.0001 |
| 977 |
OVERDOSE |
11 |
0.0001 |
| 978 |
ILLNESS |
5 |
0.0000 |
| 979 |
INJECTION SITE ERYTHEMA |
6 |
0.0000 |
| 980 |
INCORRECT DOSE ADMINISTERED |
11 |
0.0000 |
| 981 |
ASTHMA |
5 |
0.0000 |
| 982 |
VISION BLURRED |
6 |
0.0000 |
| 983 |
BREAST CANCER |
4 |
0.0000 |
| 984 |
DRUG DOSE OMISSION |
6 |
0.0000 |
| 985 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
7 |
0.0000 |
| 986 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 987 |
PRODUCT DOSE OMISSION ISSUE |
5 |
0.0000 |